THRB and cancer: TRB-CDR3s were also screened against a TCR sequence library with greater than 11.7 million unique TRB-CDR3 sequences pooled from PBMC collected from 55 control subjects without cancer as a tool to interrogate shared specificity for non-cancer-associated target antigens (33, 34).